Product/Service

GenVoy-ILM™ T-Cell Kits For mRNA

Source: Cytiva
T-Cell-Kit-Ignite-Box-and-Vials-6ml

Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.

Request Information

GenVoy-ILM™ T cell Kit for mRNA is a lipid nanoparticle (LNP) reagent mix optimized for the delivery of mRNA or CRISPR Cas9 mRNA with gRNA into human primary T cells using LNPs prepared on the NanoAssemblr™ Spark™ and Ignite™ systems.

GenVoy-ILM™ T cell Kits for mRNA offers the following benefits:

  • Highly efficient knockout and expression: The mRNA or mRNA/sgRNA can be delivered into activated human primary T cells consistently with high gene knockout efficiency.
  • High cell viability: Maintain high T cell viability, even after sequential genetic manipulation.
  • Scalable: Scale your cell therapy research on the NanoAssemblr™ platform from discovery to preclinical.
  • Validated with T cell manufacturing workflow: Optimized and validated for downstream T cell culture workflow.

The kits enable researchers to establish a clinically relevant and scalable method for ex vivo gene delivery and gene editing to advance the development of T cell therapies. These kits can be used at various stages of cell therapy research and development from discovery to preclinical across the NanoAssemblr™ platforms.

Cytiva